Abstract:Proton pump inhibitors (PPIs) are proven medications of choice for gastroesophageal reflux disease (GERD), acid-related disorders, erosive esophagitis, Barrett esophagus, prevention of gastrointestinal bleeding while on nonsteroidal anti-inflammatory drugs, eosinophilic esophagitis, peptic ulcer disease, stress ulcer prophylaxis in critically ill patients, and other indications. Best practice guidelines from several sources on the appropriate indications and duration of PPI therapy have been summarized for easy assimilation. Individualized decision with regard to PPI use is illustrated by case vignettes; best approaches are provided. The significant increase in use of PPIs for ill-defined indications over the years, associated adverse outcomes with long-term use, and consequent increase in health care costs have drawn much attention. Adverse outcomes due to PPI therapy may be categorized as unrelated or related to gastric acid inhibition. Examples of outcomes unrelated to acid inhibition include allergic reactions, acute interstitial nephritis, chronic kidney disease, poor cardiovascular outcomes, dementia, and drug interactions; consequences of acid inhibition include gastrointestinal infections, pneumonia, nutrient deficiencies, fractures, spontaneous bacterial peritonitis, and small intestinal bacterial overgrowth. Provider awareness regarding best practice guidelines on PPI use and imparting pertinent education to patients may be the rational approach to safe and effective PPI therapy. In individuals in whom the drug is not indicated, efforts at deprescribing the PPI may be attempted following discussion with the patient. Approaches include stopping the drug, reducing the dose or using "on-demand" therapy after completing the course of treatment for the specific indication. Barriers to successful deprescribing exist. Follow-up is recommended for recurrence of manifestations; in the event of recurrence, the PPI may need to be re-instituted. PPIs are valuable, irreplaceable drugs in the prevention and treatment of certain disorders for specific durations of time. Evidence nevertheless suggests that excessive and inappropriately prolonged use of PPIs is associated with a broad range of adverse effects. Education of provider and patient, stewardship, and motivation are key to appropriate use of PPIs for the right indications. Key implications for practice are offered.

Deprescribing Proton Pump Inhibitors: Updated Clinical Guidelines

The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing

[Deprescribing proton pump inhibitors : what are the clinical practice guidelines ?]

Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review

A review of proton pump inhibitor use in cystic fibrosis and considerations for deprescribing

Proton Pump Inhibitors: Rational Use and Use-Reduction – The Windsor Workshop

Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe

De-Prescribing Proton Pump Inhibitors in Patients With End Stage Kidney Disease: A Quality Improvement Project

Prescribing practices for Proton pump inhibitors among primary care physicians in England

How could proton pump inhibitors de-prescription be managed in geriatric long-term care?

The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal

Understanding the health risks and emerging concerns associated with the use of long-term proton pump inhibitors

Treatment of Gastroesophageal Reflux Disease in Adults: An Individualized Approach

Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease

Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship

Improving the feasibility of deprescribing proton pump inhibitors: GPs' insights on barriers, facilitators, and strategies

Potential Risks Associated With Long-term Use of Proton Pump Inhibitors and the Maintenance Treatment Modality for Patients With Mild Gastroesophageal Reflux Disease

Primary and Specialty Care Trainees’ Perceptions About Proton Pump Inhibitor Use

The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis

Proton Pump Inhibitors: Review of Emerging Concerns

Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.